Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UMPALA: Impact of Contraceptives on Cervico-Vaginal Mucosa
NCT04814927Phase 4Completed
- Sponsor
- Eastern Virginia Medical School
- Start
- Mar 2021
- Primary completion
- Dec 2022
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 4 trial of copper sulfate, etonogestrel, avatrombopag, medroxyprogesterone acetate in contraception, sponsored by Eastern Virginia Medical School. Started Mar 2021; status: completed.
02
Drugs
copper sulfateetonogestrelavatrombopagmedroxyprogesterone acetate
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04814927.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04814927.